Cargando…
Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo
BACKGROUND: Hyaluronan (HA) plays crucial roles in the tumourigenicity of many types of malignant tumours. 4-Methylumbelliferone (MU) is an inhibitor of HA synthesis. Several studies have shown its inhibitory effects on malignant tumours; however, none have focused on its effects on osteosarcoma. ME...
Autores principales: | Arai, E, Nishida, Y, Wasa, J, Urakawa, H, Zhuo, L, Kimata, K, Kozawa, E, Futamura, N, Ishiguro, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251882/ https://www.ncbi.nlm.nih.gov/pubmed/22045192 http://dx.doi.org/10.1038/bjc.2011.459 |
Ejemplares similares
-
Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report
por: Urakawa, Hiroshi, et al.
Publicado: (2013) -
CXCR7-mediated progression of osteosarcoma in the lungs
por: Goguet-Surmenian, E, et al.
Publicado: (2013) -
Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014) -
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
por: Tavanti, E, et al.
Publicado: (2013) -
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
por: Murray, J, et al.
Publicado: (2014)